Compare Immunovant Inc. Common Stock (IMVT) vs Nutrien Ltd (NTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Nutrien Ltd — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Nutrien Ltd trades at $69.9 (market cap $33.52B). The key difference: Nutrien Ltd is far larger — about 5.1× Immunovant Inc. Common Stock's market cap, and Nutrien Ltd pays a 3.14% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Nutrien Ltd for 59 Days on average.
| IMVT | NTR | |
|---|---|---|
Market Cap | $6.62B | $33.52B |
Volume | 1,131,364 | 1,154,412 |
Sector | Health | Basic Materials |
52-Week High | $44.96 | $83.94 |
52-Week Low | $17.03 | $53.64 |
Typical Hold Time | 0 Days | 59 Days |
Enterprise Value | $5.72B | $45.32B |
Dividend Yield | — | 3.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Nutrien (NTR) trades at $69.87, down 1.87% on the day, with mixed technical signals showing bearish moving averages but oversold RSI readings. The company reported Q2 2026 earnings of $2.61 per share, missing estimates, while revenue benefited from higher fertilizer prices. Analyst consensus remains moderately bullish with a $76.14 price target, though recent news highlights industry headwinds from potential Belarus potash imports.
The stock presents a value opportunity with reasonable P/E (14.16) and P/B (1.29) ratios, supported by strong cash flow generation. However, investors face risks from volatile fertilizer markets, competitive pressures, and cyclical agricultural demand. Near-term performance will depend on Q3 earnings results and management's strategic update at the November Investor Day.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Nutrien Ltd
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →
